newsfilter
← Latest News
Business Wire·

Dyax Corp. to Participate in the Leerink Partners 4th Annual Rare Disease Roundtable

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) announced today that executive management will participate in the Leerink Partners 4th Annual Rare Disease Roundtable being held September 30, 2015 at Le Parker Meridien Hotel in New York City. The Company is scheduled to present on Wednesday, September 30 at 3:10pm (ET).